Breaking News Instant updates and real-time market news.

FOXA

21st Century Fox

$46.90

0.07 (0.15%)

, FOX

21st Century Fox

$46.54

0.12 (0.26%)

12:39
11/06/18
11/06
12:39
11/06/18
12:39

EU approves Disney's acquisition of Fox parts, subject to conditions

The European Commission has approved, under the EU Merger Regulation, the proposed acquisition of parts of Fox (FOXA) by Disney (DIS), both U.S. based global media companies. The decision is conditional on full compliance with commitments offered by Disney. The proposed transaction would combine Disney and parts of Fox, including its film and television studios and its cable and international television businesses. The Fox Broadcasting network and stations, Fox News Channel, Fox Business Network, FS1, FS2 and Big Ten Network are not part of the transaction. To address the Commission's competition concerns, Disney committed to divest its interest in all factual channels it controls in the EEA, namely: History, H2, Crime & Investigation, Blaze and Lifetime channels. These channels are currently controlled by A+E Television Networks, which is a joint venture between Disney and Hearst. The commitments fully remove the overlap between Disney's and Fox's activities in the wholesale supply of factual channels in the EEA. Therefore, the Commission concluded that the proposed transaction, as modified by the commitments, would no longer raise competition concerns. The Commission's decision is conditional upon full compliance with the commitments. Reference Link

FOXA

21st Century Fox

$46.90

0.07 (0.15%)

FOX

21st Century Fox

$46.54

0.12 (0.26%)

DIS

Disney

$116.16

0.73 (0.63%)

  • 08

    Nov

  • 14

    Nov

  • 14

    Nov

  • 14

    Nov

  • 04

    Dec

FOXA 21st Century Fox
$46.90

0.07 (0.15%)

10/19/18
LEHM
10/19/18
INITIATION
Target $50
LEHM
Overweight
21st Century Fox reinstated with an Overweight at Barclays
Barclays analyst Kannan Venkateshwar reinstates coverage of 21st Century Fox with an Overweight rating and $50 price target. After shedding assets, the new Fox in some ways will re-emerge stronger and more focused, Venkateshwar tells investors in a research note. The analyst values New Fox at $12 per share.
11/05/18
EVER
11/05/18
INITIATION
Target $52
EVER
Outperform
21st Century Fox resumed with an Outperform at Evercore ISI
Evercore ISI analyst Vijay Jayant resumed coverage on 21st Century Fox with an Outperform and $52 price target.
10/30/18
MSCO
10/30/18
NO CHANGE
Target $95
MSCO
Overweight
WWE shares 'on sale' after pullback, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne noted that WWE (WWE) shares are down by over 30% this month, which he sees as a "rare opportunity" to buy shares of a company that he sees having both highly visible earnings growth and growing intellectual property value. He attributes the rapid selloff primarily to a broader market rotation out of risk assets due to rising interest rates and concerns over achieving long-term growth, but he thinks this "does not make sense" given that WWE's EBITDA opportunity "is not a decade away, but rather a year away," Swinburne tells investors. Two contracts underwritten by Comcast (CMCSA) and Fox (FOXA) drive the bulk of its earnings growth and its financial outlook has no immediate exposure to ratings or cord-cutting, Swinburne added. While he trimmed his price target on WWE shares to $95 from $105 after bumping up his investment expectations for 2019, the analyst maintains an Overweight rating on the stock.
10/19/18
IMPC
10/19/18
NO CHANGE
Target $32
IMPC
Outperform
MSG Networks price target raised to $32 from $29 at Imperial Capital
Imperial Capital analyst David Miller raised his price target for MSG Networks (MSGN) to $32 saying the market is "finally paying attention" to the company's de-leveraging campaign. The shares "could breakout even further" due to the potential of a new "valuation mark" set by the sale of the 21st Century Fox (FOXA) Regional Sports Networks, and specifically a sale of the YES Network to Yankee Global Enterprises, Miller tells investors in a research note. The analyst keeps an Outperform rating on MSG Networks.
FOX 21st Century Fox
$46.54

0.12 (0.26%)

09/24/18
BERN
09/24/18
NO CHANGE
BERN
Sky's bidding war outcome 'best possible result' for Disney, says Bernstein
Bernstein analyst Todd Juenger says this weekend's outcome of the bidding war for Sky (SKYAY) was "the best possible result" for Disney (DIS). The analyst argues that he never understood why Disney would want to operate a European DBS business, and never understood how Sky would contribute to Disney's DTC strategy. Rather than pay such a premium like Comcast (CMCSA), Disney can now get "paid" that premium, assuming Fox (FOXA) agrees to sell and deliver the proceeds to Disney in lieu of the shares they had promised, the analyst contends.
10/15/18
MSCO
10/15/18
NO CHANGE
Target $135
MSCO
Overweight
Disney shares appear 'compelling' at current levels, says Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne believes Disney (DIS) shares appear "compelling" at a current valuation of under 13x "core" FY20 pro forma EPS given the company's opportunity to maximize the potential of the acquired Fox (FOXA) assets and scale a direct-to-consumer business. He attributes investor reluctance to own Disney shares to uncertainty about its ability to simultaneously execute on a large acquisition, launch a global direct-to-consumer business and grow, but Swinburne sees this "complexity discount" as an opportunity, he tells investors. He maintains an Overweight rating on Disney shares with a $135 price target.
10/15/18
MSCO
10/15/18
INITIATION
Target $53
MSCO
Overweight
21st Century Fox resumed with an Overweight at Morgan Stanley
Morgan Stanley analyst Benjamin Swinburne resumed coverage of 21st Century Fox (FOXA) with an Overweight rating and $53 price target, based on his valuation of $12 per share for "New Fox" and roughly $41 per share for "RemainCo." Swinburne said he expects New Fox's cable networks to deliver 7-8% annualized distribution fee growth through FY22, which he notes is higher growth than he projects for the U.S. TV assets it is selling to Disney (DIS). He projects roughly $2.1B of annual free cash flow generated on average for FY20-FY22, ramping up to nearly $2.5B in FY23, which he sees being used for dividends, buybacks and likely more M&A.
DIS Disney
$116.16

0.73 (0.63%)

10/19/18
LEHM
10/19/18
UPGRADE
Target $130
LEHM
Overweight
Disney upgraded to Overweight from Equal Weight at Barclays
Barclays analyst Kannan Venkateshwar upgraded Disney to Overweight from Equal Weight and raised his price target for the shares to $130 from $105.
10/19/18
LEHM
10/19/18
UPGRADE
Target $130
LEHM
Overweight
Barclays sees Disney becoming 'core holding' again, upgrades to Overweight
Barclays analyst Kannan Venkateshwar upgraded Disney to Overweight from Equal Weight and raised his price target for the shares to $130 from $105. The shares closed yesterday down 91c to $116.18. The stock is likely to become a "core holding" again, Venkateshwar tells investors in a research note partially titled "The Force Awakens." While almost everything about Disney's over-the-top story is conjecture and success is not a given, the company has the "key mix of assets to be successful and the opportunity from this pivot could be substantial," contends the analyst. He believes Disney's investor day could prove to be a catalyst to frame the scale of the OTT opportunity and help the company build a credible terminal value "story"' around the stock. And the analyst thinks current media multiples are more about terminal value optionality than near-term core trends. "In this respect, there are a few other names with a credible terminal value story other than Disney," writes Venkateshwar.
10/19/18
10/19/18
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Disney (DIS) upgraded to Overweight from Equal Weight at Barclays with analyst Kannan Venkateshwar saying the stock is likely to become a "core holding" again. 2. Dentsply Sirona (XRAY) double upgraded to Buy from Sell at Goldman Sachs with analyst Nathan Rich saying he now believes consensus estimates are achievable and that Dentsply's valuation is attractive relative to Medtech peers. 3. PayPal (PYPL) upgraded to Buy from Neutral at BTIG with analyst Mark Palmer saying the company's Venmo monetization progress was the deciding factor in his rating change. 4. Roku (ROKU) upgraded to Outperform from Sector Perform at RBC Capital with analyst Mark Mahaney saying the company's valuation has become more attractive following a 25% pullback in its stock price but believes Roku offers the "best opportunity for upwards estimates revisions." 5. O'Reilly Automotive (ORLY) upgraded to Overweight from Neutral at JPMorgan with analyst Christopher Horvers saying he sees "strong" fundamentals with "structurally positive industry factors." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
11/06/18
CLVD
11/06/18
NO CHANGE
CLVD
Workday likely closed Disney deal at end of Q3, says Cleveland Research
Cleveland Research said research suggests Workday (WDAY) likely closed the Disney (DIS) deal at the end of Q3. The firm's analyst believes large deal likely finished ahead of Q3 expectations, with prior work indicating Comcast (CMSA) and H&R Block (HRB) also were won in the quarter.

TODAY'S FREE FLY STORIES

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:45
02/19/19
02/19
07:45
02/19/19
07:45
Hot Stocks
Breaking Hot Stocks news story on Noble Midstream »

Noble Midstream sees FY19…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

07:45
02/19/19
02/19
07:45
02/19/19
07:45
General news
Global Risks Ebb and Flow: »

Global Risks Ebb and…

XPO

XPO Logistics

$52.01

-7.535 (-12.65%)

07:44
02/19/19
02/19
07:44
02/19/19
07:44
Recommendations
XPO Logistics analyst commentary  »

XPO Logistics price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:43
02/19/19
02/19
07:43
02/19/19
07:43
Hot Stocks
Noble Midstream sees FY19 capital budget $335M-$375M »

Noble Midstream's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:42
02/19/19
02/19
07:42
02/19/19
07:42
Hot Stocks
Noble Midstream sees adjusted EBITDA from partnership of at least $300M in 2020 »

Anticipates adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CSX

CSX

$72.52

0.91 (1.27%)

07:41
02/19/19
02/19
07:41
02/19/19
07:41
Downgrade
CSX rating change  »

CSX downgraded to Sector…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 28

    May

HEXO

HEXO Corp

$5.57

0.17 (3.15%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Initiation
HEXO Corp initiated  »

HEXO Corp initiated with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WIN

Windstream

$3.37

0.2 (6.31%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Downgrade
Windstream rating change  »

Windstream downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

AMSC

AMSC

$15.00

-0.8 (-5.06%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Conference/Events
AMSC management to meet with Roth Capital »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 20

    Feb

NBLX

Noble Midstream

$32.09

-0.04 (-0.12%)

07:40
02/19/19
02/19
07:40
02/19/19
07:40
Hot Stocks
Noble Midstream sees FY19 adjusted EBITDA $340M-$390M »

"Entering 2019, we…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

07:40
02/19/19
02/19
07:40
02/19/19
07:40
General news
Treasury Market Outlook: bond yields have dipped slightly lower amid risk-off flows »

Treasury Market Outlook:…

CEQP

Crestwood Equity

$32.82

-0.06 (-0.18%)

07:39
02/19/19
02/19
07:39
02/19/19
07:39
Earnings
Crestwood Equity sees FY19 net income $105M-$135M »

Sees FY 19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

PODD

Insulet

$88.51

3.68 (4.34%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Insulet analyst commentary  »

Insulet price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Feb

NWL

Newell Brands

$17.15

-4.55 (-20.97%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Recommendations
Newell Brands analyst commentary  »

Newell Brands price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

CEQP

Crestwood Equity

$32.82

-0.06 (-0.18%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Earnings
Crestwood Equity reports Q4 EPS 57c, may not compare to consensus 13c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

IRBT

iRobot

$119.34

4 (3.47%)

07:38
02/19/19
02/19
07:38
02/19/19
07:38
Downgrade
iRobot rating change  »

iRobot downgraded to Hold…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WPC

W.P. Carey

$75.16

-0.02 (-0.03%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
W.P. Carey to invest $75M in food production facility in San Antonio »

W. P. Carey announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Feb

EBAY

eBay

$36.59

0.28 (0.77%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
eBay analyst commentary  »

eBay January trends…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Mar

MIDD

Middleby

$126.19

2.13 (1.72%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Hot Stocks
Middleby announces retirement of CEO Selim Bassoul »

The Middleby Corporation…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PEP

PepsiCo

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
PepsiCo analyst commentary  »

PepsiCo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

  • 18

    May

PATK

Patrick Industries

$47.06

2.01 (4.46%)

07:36
02/19/19
02/19
07:36
02/19/19
07:36
Recommendations
Patrick Industries analyst commentary  »

Patrick Industries price…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SB

Safe Bulkers

$1.60

-0.01 (-0.62%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
Safe Bulkers reports Q4 adj. EPS 7c, consensus 8c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

NXRT

NexPoint Residential

$38.40

0.13 (0.34%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Earnings
NexPoint Residential sees FY19 AFFO $2.16, consensus $2.24 »

Sees FY19 Same Store NOI…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Feb

DE

Deere

$158.99

-3.45 (-2.12%)

07:35
02/19/19
02/19
07:35
02/19/19
07:35
Recommendations
Deere analyst commentary  »

Too early to write off…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 27

    Feb

BHVN

Biohaven Pharmaceutical

$45.32

1.36 (3.09%)

07:34
02/19/19
02/19
07:34
02/19/19
07:34
Hot Stocks
Biohaven Pharmaceutical's verdiperstat receives FDA orphan drug designation »

Biohaven Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.